Monica M. Mita
Institute for Drug Development; Cancer Therapy and Research Center; San Antonio
Texas 78229
USA
Name/email consistency: high
- The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Mita, M.M., Mita, A., Rowinsky, E.K. Cancer Biol. Ther. (2003)